Parameter
| Biomarker | miR-146a | Full name | MicroRNA-146a | Molecular Type | Nucleic acid |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Serum (RT-qPCR) | ||
| Pathobiological Mechanisms | Progression-free survival and overall survival after treatment with the R-CHOP regimen | ||||
| Clinical Availability Status | Research validation phase: Preliminary validation of 72 patients, lacking multicenter external data, and non-unified testing procedures. | ||||
| Notes and Dynamics | Exploring the Value of Rituximab in Monitoring Minimal Residual Disease in Combination with Rituximab. | ||||